oleic acid has been researched along with Parkinson Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, Y; Hiep, NT; Hong, S; Hwang, BY; Kim, DW; Kwon, J; Lee, D; Lee, HJ; Mar, W | 1 |
| Akhtar, MS; Mahdi, AA; Pandey, S; Rumman, M; Singh, B; Ubaid, S | 2 |
| Barrasa, MI; Baru, V; Becuwe, M; Clish, CB; Dettmer, U; Fanning, S; Farese, RV; Freyzon, Y; Haque, A; Ho, GPH; Hofbauer, HF; Imberdis, T; Jaenisch, R; Kim, TE; Kohlwein, SD; Landgraf, D; Lindquist, S; Lou, Y; Newby, G; Noble, T; Nuber, S; Pincus, D; Ramalingam, N; Sandoe, J; Selkoe, D; Soldner, F; Srinivasan, S; Termine, D; Terry-Kantor, E; Walther, TC; Welte, MA | 1 |
| Chavarría, C; Durán, R; Rubbo, H; Souza, JM; Trostchansky, A | 1 |
| Borda, LJ; Miteva, M; Paus, R; Wikramanayake, TC | 1 |
| Oresti, GM; Rodríguez Diez, G; Salvador, GA; Sánchez Campos, S | 1 |
| Cantor, CR; Chou, VP; Langston, JW; Manning-Boğ, AB; Molinari, RJ; Pollock, E; Shchepinov, MS | 1 |
2 review(s) available for oleic acid and Parkinson Disease
| Article | Year |
|---|---|
Nitroalkylation of α-Synuclein by Nitro-Oleic Acid: Implications for Parkinson's Disease.
Topics: alpha-Synuclein; Amyloid; Humans; Neurodegenerative Diseases; Oleic Acid; Parkinson Disease; Phospholipids | 2019 |
Seborrheic dermatitis-Looking beyond Malassezia.
Topics: Animals; Causality; Dandruff; Dermatitis, Seborrheic; Dermatomycoses; Disease Susceptibility; Epidermis; Humans; Immunocompromised Host; Malassezia; Membrane Proteins; Mice; Mice, Knockout; Mice, Transgenic; Models, Biological; Neurosecretory Systems; Oleic Acid; Parkinson Disease; Propionibacterium; Scalp Dermatoses; Sebaceous Glands; Staphylococcus aureus; Transcription Factors; Tumor Suppressor Proteins | 2019 |
6 other study(ies) available for oleic acid and Parkinson Disease
| Article | Year |
|---|---|
Chemical Constituents Isolated from the Root Bark of Cudrania tricuspidata and Their Potential Neuroprotective Effects.
Topics: Animals; Cell Death; Disease Models, Animal; Glucose; Ischemia; Moraceae; Neuroprotective Agents; Nuclear Magnetic Resonance, Biomolecular; Parkinson Disease; Plant Bark; Plant Roots; Republic of Korea; Xanthones | 2016 |
SIRT1 Mediates Neuroprotective and Neurorescue Effects of Camel α-Lactalbumin and Oleic Acid Complex on Rotenone-Induced Parkinson's Disease.
Topics: Animals; Camelus; Lactalbumin; Neuroprotection; Neuroprotective Agents; Oleic Acid; Oxidative Stress; Parkinson Disease; Rotenone; Sirtuin 1 | 2022 |
Elucidating the Neuroprotective Role of Formulated Camel α-Lactalbumin-Oleic Acid Complex by Curating the SIRT1 Pathway in Parkinson's Disease Model.
Topics: Animals; Camelus; Lactalbumin; Oleic Acid; Parkinson Disease; Sirtuin 1 | 2020 |
Lipidomic Analysis of α-Synuclein Neurotoxicity Identifies Stearoyl CoA Desaturase as a Target for Parkinson Treatment.
Topics: alpha-Synuclein; Animals; Antiparkinson Agents; Caenorhabditis elegans; Cell Line; Cerebral Cortex; Diglycerides; Disease Models, Animal; Dopaminergic Neurons; Drug Discovery; Enzyme Inhibitors; Humans; Induced Pluripotent Stem Cells; Lipid Droplets; Lipid Metabolism; Metabolomics; Mice, Inbred C57BL; Mice, Transgenic; Molecular Targeted Therapy; Nerve Degeneration; Neural Stem Cells; Neurons; Oleic Acid; Parkinson Disease; Rats, Sprague-Dawley; Saccharomyces cerevisiae; Stearoyl-CoA Desaturase; Triglycerides | 2019 |
Dopaminergic Neurons Respond to Iron-Induced Oxidative Stress by Modulating Lipid Acylation and Deacylation Cycles.
Topics: Acylation; Animals; Arachidonic Acid; Cell Line; Copper; Dopaminergic Neurons; Iron; Iron Overload; Lipid Metabolism; Lipid Peroxidation; Membrane Potential, Mitochondrial; Mitochondria; Oleic Acid; Oxidation-Reduction; Oxidative Stress; Parkinson Disease; Phospholipids; Rats; Reactive Oxygen Species; Triglycerides | 2015 |
Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; alpha-Linolenic Acid; Animals; Cell Death; Corpus Striatum; Deuterium; Disease Models, Animal; Fatty Acids, Unsaturated; Linoleic Acid; Mice; Mice, Inbred C57BL; Nerve Degeneration; Oleic Acid; Oxidative Stress; Parkinson Disease; Parkinsonian Disorders; Substantia Nigra | 2011 |